TRIM21 and myositis disease: As shown in our model of HRS-induced myositis, there is compelling evidence that autoantibodies targeting HRS, Ro52, and Ro60 are independently generated in BALF as well as serum—suggesting that the lung microenvironment may represent a primary site for breakdown of immune tolerance.